Stock comparison
Mettler-Toledo International
Dr. Reddy's Laboratories Limited
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
MTD
Mettler-Toledo International
Market cap
$22.29B
Sector
Healthcare
RDY
Dr. Reddy's Laboratories Limited
Market cap
$11.32B
Sector
Healthcare
Overall winner
Mettler-Toledo International MTD
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | MTD | RDY | Winner |
|---|---|---|---|
| Warren Buffett | 69B | 57C | MTD |
| Benjamin Graham | 65B | 72B | RDY |
| Philip Fisher | 63C | 61C | MTD |
| Peter Lynch | 66B | 55C | MTD |
| Joel Greenblatt | 68B | 46D | MTD |
| Charlie Munger | 74B | 49D | MTD |
| Terry Smith | 70B | 45D | MTD |
Side-by-side metrics
| Metric | MTD | RDY |
|---|---|---|
| Market cap | $22.29B | $11.32B |
| P/E (TTM) | 25.3x | 26.0x |
| EV/EBIT | 21.6x | 24.0x |
| ROIC (TTM) | 36.09% | 8.07% |
| Gross margin | 57.79% | 52.77% |
| Net margin | 21.4% | 12.76% |
| Revenue CAGR 5y | 2.01% | 13.31% |
| EPS CAGR 5y | 6.12% | 17.36% |
| Debt / Equity | - | 0.2x |
| Dividend yield | 0.0% | 0.6% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
MTD leads on
- Debt / Equity-vs 0.2x+100%
- ROIC (TTM)36.09%vs 8.07%+78%
- Market cap$22.29Bvs $11.32B+49%
- Net margin21.4%vs 12.76%+40%
RDY leads on
- Dividend yield0.6%vs 0.0%+100%
- Revenue CAGR 5y13.31%vs 2.01%+85%
- EPS CAGR 5y17.36%vs 6.12%+65%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.